- Thoracic Oncology ProgramSmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 4thNew Haven, CT 06511
Gavitt Woodard, MD
Biography
Gavitt Woodard, MD, is a thoracic surgeon who treats diseases that affect the chest. She specializes in the care of patients with lung cancer, and approaches each new patient as part of a multidisciplinary care team that also includes oncologists and radiation oncologists.
Patients are sometimes surprised to learn that lung cancer has undergone a “complete revolution” in the past decade, with screening CT scans, robotic surgery, genetic testing, targeted therapy, and immunotherapy, Dr. Woodard explains. “The vast majority of our early-stage lung cancer operations are done robotically with small incisions, less pain, and faster recovery times,” she says, adding that robotic technology is only going to improve with time.
Dr. Woodard says she always wanted to become a physician, but didn’t decide to become a surgeon until she was 16 years old and had surgery herself. “I love that surgery directly fixes a problem, the result is immediate, and it is so satisfying,” she says. “I considered many surgical specialties but was drawn to thoracic surgery because of the great lung anatomy, lung cancer biology, and the complexity of the operations.”
An assistant professor at Yale School of Medicine, Dr. Woodard performs research on biomarkers of early-stage lung cancer and on the tumor immune microenvironment in the laboratory of Lieping Chen, MD, PhD. Dr. Chen was the first to discover a protein called PD-L1, and he established the important role of this pathway in cancer immunotherapy.
Titles
- Assistant Professor of Surgery (Thoracic )
Education & Training
- Cardiothoracic Surgery FellowUniversity of California San Francisco (2020)
- General Surgery ResidentUniversity of California San Francisco (2018)
- MDStanford University (2011)
- BSHarvard University, Neurobiology (2006)
Additional Information
- SPORE in Lung Cancer Career Enhancement Program Grant: Yale (2022)
- Robotics Fellowship: American Association of Thoracic Surgeons (2019)
- Chief Resident Achievement Award: University of California San Francisco (2018)
- Resident Research Award, Best Presentation: University of California San Francisco (2016)
- Resident Research Award: American College of Surgeons (2015)
- Resident Research Award, Best Presentation: University of California San Francisco (2015)
- AB of Thoracic Surgery, Thoracic & Cardiac Surgery (2022)
- Zhan P, Boffa D, Woodard G. Further insights into MARS 2. The Lancet Respiratory Medicine 2024, 12: e52. PMID: 39214641, DOI: 10.1016/s2213-2600(24)00251-0.
- Woodard G, Jablons D. Shades of Gray: Do Never Smokers Benefit From Lung Cancer Screening Programs? Journal Of Thoracic Oncology 2024, 19: 1135-1137. PMID: 39111999, DOI: 10.1016/j.jtho.2024.06.007.
- Higaki A, Papageorge M, Waldron C, Huggins L, Brinker M, Erez E, Milewski R, Woodard G, Antonoff M, Lee M. Gender Representation Trends in Cardiothoracic Surgery Journal Editorial Boards. Journal Of Thoracic And Cardiovascular Surgery 2024 PMID: 38944272, DOI: 10.1016/j.jtcvs.2024.06.019.
- Detterbeck F, Woodard G, Bader A, Dacic S, Grant M, Park H, Tanoue L. The Proposed 9th Edition TNM Classification of Lung Cancer. CHEST Journal 2024 PMID: 38885896, DOI: 10.1016/j.chest.2024.05.026.
- Wang A, Rosenberg G, Woodard G, Dhanasopon A, Udelsman B. Image-guided and bronchoscopic localization techniques used to facilitate minimally invasive pulmonary metastasectomies. Video-Assisted Thoracic Surgery 2024, 0: 0-0. DOI: 10.21037/vats-23-80.
- Woodard G, Dacic S. Should the TNM Staging of NSCLC Evolve Beyond Anatomical Descriptors? Journal Of Thoracic Oncology 2024, 19: 663-665. PMID: 38719420, DOI: 10.1016/j.jtho.2024.01.004.
- Ely S, Van Udelsman B, Bader A, Woodard G. Chest Wall Anomaly Presenting as Pulmonary Nodule. Annals Of Thoracic Surgery Short Reports 2024, 2: 88-90. DOI: 10.1016/j.atssr.2023.11.021.
- Detterbeck F, Ely S, Udelsman B, Blasberg J, Boffa D, Dhanasopon A, Mase V, Woodard G. So Now We Know—Reflections on the Extent of Resection for Stage I Lung Cancer. Clinical Lung Cancer 2023, 25: e113-e123. PMID: 38310034, DOI: 10.1016/j.cllc.2023.12.007.
- Woodard G, Cho C, Chen L. Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis? Annals Of Surgical Oncology 2023, 31: 25-27. PMID: 37899411, DOI: 10.1245/s10434-023-14388-1.
- Udelsman B, Detterbeck F, Tanoue L, Mase V, Boffa D, Blasberg J, Dhanasopon A, Ely S, Mazzarelli L, Bader A, Woodard G. Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network. Journal Of Computer Assisted Tomography 2023, 48: 222-225. PMID: 37832536, DOI: 10.1097/rct.0000000000001549.
- Woodard G, Udelsman B, Prince S, Blasberg J, Dhanasopon A, Gange C, Traube L, Mase V, Boffa D, Detterbeck F, Bader A. Brief Report: Increasing Prevalence of Ground-Glass Nodules and Semisolid Lung Lesions on Outpatient Chest Computed Tomography Scans. JTO Clinical And Research Reports 2023, 4: 100583. PMID: 38074773, PMCID: PMC10709040, DOI: 10.1016/j.jtocrr.2023.100583.
- Woodard G, Ding V, Cho C, Brand N, Kratz J, Jones K, Jablons D. Comparative genomics between matched solid and lepidic portions of semi-solid lung adenocarcinomas. Lung Cancer 2023, 180: 107211. PMID: 37121213, PMCID: PMC10900430, DOI: 10.1016/j.lungcan.2023.107211.
- Grant M, Woodard G, Goldberg S. The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer. Hematology/Oncology Clinics Of North America 2023, 37: 513-531. PMID: 37024389, DOI: 10.1016/j.hoc.2023.02.003.
- Woodard G, Tanoue L, Detterbeck F, Boffa D, Mase V, Blasberg J, Dhanasopon A, Gosangi B, Traube L, Bader A. PP01.12 Increasing Diagnosis of Ground Glass Nodules and Semi-Solid Lung Lesions on Chest CT Scans over the Past Decade. Journal Of Thoracic Oncology 2023, 18: e15. DOI: 10.1016/j.jtho.2022.09.038.
- Woodard G, Boffa D, Blasberg J. Thoracic CT follow-up after non-small-cell lung cancer resection. The Lancet Oncology 2022, 23: e484. PMID: 36328013, DOI: 10.1016/s1470-2045(22)00618-0.
- Ely S, Udelsman B, Homer R, Dhanasopon A, Woodard G. EP14.05-021 Promising Long-Term Survival after Surgical Resection of Early Stage Small Cell Lung Cancer in a Modern Single-Center Cohort. Journal Of Thoracic Oncology 2022, 17: s552-s553. DOI: 10.1016/j.jtho.2022.07.996.
- Lee M, Woodard G, Assi R. Connection through cardiothoracic surgery subspecialty collaboration: Strategies for Early Faculty Peer Network Development. JTCVS Open 2022, 12: 329-334. PMID: 36590730, PMCID: PMC9801233, DOI: 10.1016/j.xjon.2022.07.008.
- Detterbeck FC, Mase VJ, Li AX, Kumbasar U, Bade BC, Park HS, Decker RH, Madoff DC, Woodard GA, Brandt WS, Blasberg JD. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813747, PMCID: PMC9264068, DOI: 10.21037/jtd-21-1824.
- Park HS, Detterbeck FC, Madoff DC, Bade BC, Kumbasar U, Mase VJ, Li AX, Blasberg JD, Woodard GA, Brandt WS, Decker RH. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813762, PMCID: PMC9264060, DOI: 10.21037/jtd-21-1826.
- Bade BC, Blasberg JD, Mase VJ, Kumbasar U, Li AX, Park HS, Decker RH, Madoff DC, Brandt WS, Woodard GA, Detterbeck FC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813753, PMCID: PMC9264070, DOI: 10.21037/jtd-21-1825.
- Detterbeck FC, Blasberg JD, Woodard GA, Decker RH, Kumbasar U, Park HS, Mase VJ, Bade BC, Li AX, Brandt WS, Madoff DC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-making. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813719, PMCID: PMC9264102, DOI: 10.21037/jtd-21-1823.
- Woodard GA, Cho C, Chen L. Could Programmed Death-Ligand 1 Copy Number Alterations be a Predictive Biomarker for Immunotherapy Response? Journal Of Thoracic Oncology 2022, 17: 592-595. PMID: 35465963, DOI: 10.1016/j.jtho.2022.03.009.
- Combes A, Samad B, Tsui J, Chew N, Yan P, Reeder G, Kushnoor D, Shen A, Davidson B, Barczak A, Adkisson M, Edwards A, Naser M, Barry K, Courau T, Hammoudi T, Argüello R, Rao A, Olshen A, Consortium T, Spitzer M, Fong L, Nelson A, Kumar R, Lee J, Burra A, Hsu J, Hackett C, Tolentino K, Sjarif J, Johnson P, Shao E, Abrau D, Lupin L, Shaw C, Collins Z, Lea T, Corvera C, Nakakura E, Carnevale J, Alvarado M, Loo K, Chen L, Chow M, Grandis J, Ryan W, El-Sayed I, Jablons D, Woodard G, Meng M, Porten S, Okada H, Tempero M, Ko A, Kirkwood K, Vandenberg S, Guevarra D, Oropeza E, Cyr C, Glenn P, Bolen J, Morton A, Eckalbar W, Cai C, Zhan J, Davis K, Kelley R, Chapman J, Atreya C, Patel A, Daud A, Ha P, Diaz A, Kratz J, Collisson E, Fragiadakis G, Erle D, Boissonnas A, Asthana S, Chan V, Krummel M. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell 2021, 185: 184-203.e19. PMID: 34963056, PMCID: PMC8862608, DOI: 10.1016/j.cell.2021.12.004.
- Gupta AR, Woodard GA, Jablons DM, Mann MJ, Kratz JR. Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay. Future Oncology 2021, 17: 4785-4795. PMID: 34435876, PMCID: PMC9039775, DOI: 10.2217/fon-2021-0517.
- Woodard GA, Kratz JR, Haro G, Gubens MA, Blakely CM, Jones KD, Mann MJ, Jablons DM. Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non–Squamous Non–Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy. Clinical Lung Cancer 2021, 22: 587-595. PMID: 34544620, DOI: 10.1016/j.cllc.2021.08.008.
- Woodard GA, Li A, Boffa DJ. Role of adjuvant therapy in T1-2N0 resected non–small cell lung cancer. Journal Of Thoracic And Cardiovascular Surgery 2021, 163: 1685-1692. PMID: 34334172, DOI: 10.1016/j.jtcvs.2021.05.053.
- Woodard GA, Fels Elliott DR, Yap A, Haro GJ, Kratz JR, Mann MJ, Jones KD, Jablons DM. Resectability, Recurrence, and Risk Stratification of Giant Solitary Fibrous Tumors in the Thoracic Cavity. Annals Of Surgical Oncology 2021, 28: 4953-4959. PMID: 33728541, DOI: 10.1245/s10434-021-09757-7.
- Woodard G, Kratz J, Haro G, Gubens M, Blakely C, Jones K, Mann M, Jablons D. MO01.13 Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit from Adjuvant Chemotherapy. Journal Of Thoracic Oncology 2021, 16: s21. DOI: 10.1016/j.jtho.2020.10.061.
- Yang YW, Marrufo A, Chase J, Woodard GA, Jablons DM, Lemjabbar-Alaoui H. Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma. Experimental Lung Research 2020, 47: 9-25. PMID: 33107354, DOI: 10.1080/01902148.2020.1836691.
- Hamilton B, Haro G, Woodard G, Sheu B, Kratz J, Mann M, Jablons D. Everybody Must Get Scanned? Molecular Risk Stratification May Limit the Need for CT Surveillance Following Surgical Resection of Early-Stage Non-Squamous, Non-Small Cell Lung Cancer. 2020, a7693-a7693. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7693.
- Woodard GA, Jablons DM. Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma. Translational Lung Cancer Research 2020, 9: s86-s91. PMID: 32206574, PMCID: PMC7082252, DOI: 10.21037/tlcr.2020.01.08.
- Haro GJ, Sheu B, Cook NR, Woodard GA, Mann MJ, Kratz JR. Comparison of Conventional TNM and Novel TNMB Staging Systems for Non–Small Cell Lung Cancer. JAMA Network Open 2019, 2: e1917062. PMID: 31808928, PMCID: PMC6902768, DOI: 10.1001/jamanetworkopen.2019.17062.
- Woodard G, Crockard J, Anand A, Ding V, Jones K, Gubens M, Blakely C, Jahan T, Jablons D. P2.06-09 Drop the Scalpel: Long-Term Survival in Mesothelioma Without Extrapleural Pneumonectomy or Pleurectomy Decortication. Journal Of Thoracic Oncology 2019, 14: s758-s759. DOI: 10.1016/j.jtho.2019.08.1627.
- Woodard G, Ding V, Kim I, Jones K, Chavez G, Haro G, Kratz J, Mann M, Rotow J, Blakely C, Jablons D. MA06.09 Timing of Driver Mutation Development and the Genetic Evolution of Semi-Solid Lung Nodules into Early NSCLC. Journal Of Thoracic Oncology 2019, 14: s271-s272. DOI: 10.1016/j.jtho.2019.08.544.
- Woodard GA, Lee H, Fels Elliott DR, Jones KD, Wong J, Jablons DM, Ihnken K. Case report: recurrent metastatic breast cancer in internal mammary dissection bed discovered at the time of coronary bypass. Journal Of Cardiothoracic Surgery 2019, 14: 158. PMID: 31488186, PMCID: PMC6728940, DOI: 10.1186/s13019-019-0980-1.
- Carbone M, Adusumilli PS, Alexander HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley‐Bosco E, Galateau‐Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, Severson DT, Taioli E, Tsao A, Woodard G, Yang H, Zauderer MG, Pass HI. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA A Cancer Journal For Clinicians 2019, 69: 402-429. PMID: 31283845, PMCID: PMC8192079, DOI: 10.3322/caac.21572.
- Kratz JR, Haro GJ, Cook NR, He J, Van Den Eeden SK, Woodard GA, Gubens MA, Jahan TM, Jones KD, Kim IJ, He B, Jablons DM, Mann MJ. Incorporation of a Molecular Prognostic Classifier Improves Conventional Non–Small Cell Lung Cancer Staging. Journal Of Thoracic Oncology 2019, 14: 1223-1232. PMID: 30959120, DOI: 10.1016/j.jtho.2019.03.015.
- Woodard GA, Wieselthaler GM. Cast of the Right Bronchial Tree. New England Journal Of Medicine 2018, 379: 2151-2151. PMID: 30485771, DOI: 10.1056/nejmicm1806493.
- Rotow JK, Woodard GA, Urisman A, McCoach CE, Bivona TG, Elicker BM, Jablons DM, Blakely CM. Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation. Clinical Lung Cancer 2018, 20: e137-e141. PMID: 30553716, DOI: 10.1016/j.cllc.2018.11.003.
- Woodard G, Wang S, Kratz J, Haro G, Gubens M, Blakely C, Jahan T, Jones K, Mann M, Jablons D. P2.16-12 Expanded Data Confirm Molecular Testing Identifies Lung Adenocarcinoma Patients, Including Stage IA, Who Benefit from Adjuvant Chemotherapy. Journal Of Thoracic Oncology 2018, 13: s835. DOI: 10.1016/j.jtho.2018.08.1487.
- Haro G, Kratz J, Cook N, He J, Van Den Eeden S, Woodard G, Gubens M, Jahan T, Jones K, Kim I, He B, Jablons D, Mann M. P3.03-24 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging. Journal Of Thoracic Oncology 2018, 13: s919. DOI: 10.1016/j.jtho.2018.08.1701.
- Jablons D, Woodard G. MS31.03 Targeting the Hippo Pathway. Journal Of Thoracic Oncology 2018, 13: s306. DOI: 10.1016/j.jtho.2018.08.205.
- Mutti L, Peikert T, Robinson BWS, Scherpereel A, Tsao AS, de Perrot M, Woodard GA, Jablons DM, Wiens J, Hirsch FR, Yang H, Carbone M, Thomas A, Hassan R. Scientific Advances and New Frontiers in Mesothelioma Therapeutics. Journal Of Thoracic Oncology 2018, 13: 1269-1283. PMID: 29966799, PMCID: PMC6643278, DOI: 10.1016/j.jtho.2018.06.011.
- Wang S, Woodard G, Lucas C, Rogers S, Jablons D. 2460. Journal Of Clinical And Translational Science 2017, 1: 79-79. PMCID: PMC6799655, DOI: 10.1017/cts.2017.280.
- Woodard GA, Yang YL, You L, Jablons DM. Drug development against the hippo pathway in mesothelioma. Translational Lung Cancer Research 2017, 6: 335-342. PMID: 28713678, PMCID: PMC5504108, DOI: 10.21037/tlcr.2017.06.02.
- Woodard GA, Wang SX, Kratz JR, Zoon-Besselink CT, Chiang CY, Gubens MA, Jahan TM, Blakely CM, Jones KD, Mann MJ, Jablons DM. Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2017, 19: 58-64. PMID: 28645632, DOI: 10.1016/j.cllc.2017.05.015.
- Wang S, Woodard G, Umetsu S, Tsai K, Daud A, Jones K, Jablons D. Melanotic Schwannoma. AJSP Review And Reports 2017, 22: 161-163. DOI: 10.1097/pcr.0000000000000200.
- Kratz JR, Woodard G, Jablons DM. Management of Lung Cancer Invading the Superior Sulcus. Thoracic Surgery Clinics 2017, 27: 149-157. PMID: 28363369, DOI: 10.1016/j.thorsurg.2017.01.008.
- Woodard G, Zoon-Besselink C, Wang S, Jones K, Jablons D. P2.04-039 Long-Term Risk of Recurrence in Benign Pleural Solitary Fibrous Tumors: A Single Institution Review Topic: Esophageal Cancer and Other Malignancies. Journal Of Thoracic Oncology 2017, 12: s1020-s1021. DOI: 10.1016/j.jtho.2016.11.1419.
- Woodard G, Crockard J, Zoon-Besselink C, Kratz J, Gubens M, Jahan T, Blakely C, Jones K, Mann M, Jablons D. OA19.06 Adjuvant Chemotherapy Decisions Based on Molecular Risk Status Improves Outcomes in Early Stage, Non-Small Cell Lung Cancer. Journal Of Thoracic Oncology 2017, 12: s320. DOI: 10.1016/j.jtho.2016.11.341.
- Kratz J, Cook N, Woodard G, Jones K, Gubens M, Jahan T, Kim I, He B, Jablons D, Mann M. P1.03-066 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer TNM Staging Topic: Staging. Journal Of Thoracic Oncology 2017, 12: s584-s585. DOI: 10.1016/j.jtho.2016.11.738.
- Woodard G, Ding V, Rosenblum M, Leguay F, Zoon-Besselink C, Jones K, Lea T, Mcdermott M, Kim I, Jablons D. MA17.01 Microarray Identification of Genetic Drivers of Brain Metastasis in Lung Adenocarcinoma. Journal Of Thoracic Oncology 2017, 12: s441-s442. DOI: 10.1016/j.jtho.2016.11.515.
- Wang S, Woodard G, Rosenblum M, Zoon-Besselink C, Jones K, Jablons D. P3.01-013 Case Report of Melanotic Schwannoma: A Challenging Diagnosis Made Clear through Genetic Testing Topic: Morphology. Journal Of Thoracic Oncology 2017, 12: s1126. DOI: 10.1016/j.jtho.2016.11.1579.
- Kang HC, Kim JI, Chang HK, Woodard G, Choi YS, Ku JL, Jablons DM, Kim IJ. FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid. Scientific Reports 2016, 6: 34022. PMID: 27677402, PMCID: PMC5039724, DOI: 10.1038/srep34022.
- Woodard GA, Crockard JC, Clary‐Macy C, Zoon‐Besselink C, Jones K, Korn WM, Ko AH, Gottschalk AR, Rogers SJ, Jablons DM. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long‐term survival outcomes with minimal morbidity. Journal Of Surgical Oncology 2016, 114: 838-847. PMID: 27569043, DOI: 10.1002/jso.24409.
- Woodard GA, Jones KD, Jablons DM. Lung Cancer Staging and Prognosis. Cancer Treatment And Research 2016, 170: 47-75. PMID: 27535389, DOI: 10.1007/978-3-319-40389-2_3.
- Li H, Yue D, Jin JQ, Woodard GA, Tolani B, Luh TM, Giroux-Leprieur E, Mo M, Chen Z, Che J, Zhang Z, Zhou Y, Wang L, Hao X, Jablons D, Wang C, He B. Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas. Oncotarget 2016, 5: 80415-80425. PMID: 27533453, PMCID: PMC5348330, DOI: 10.18632/oncotarget.11246.
- Carbone M, Kanodia S, Chao A, Miller A, Wali A, Weissman D, Adjei A, Baumann F, Boffetta P, Buck B, de Perrot M, Dogan AU, Gavett S, Gualtieri A, Hassan R, Hesdorffer M, Hirsch FR, Larson D, Mao W, Masten S, Pass HI, Peto J, Pira E, Steele I, Tsao A, Woodard GA, Yang H, Malik S. Consensus Report of the 2015 Weinman International Conference on Mesothelioma. Journal Of Thoracic Oncology 2016, 11: 1246-1262. PMID: 27453164, PMCID: PMC5551435, DOI: 10.1016/j.jtho.2016.04.028.
- Kang H, Kim H, Lee S, Mendez P, Kim J, Woodard G, Jen K, Fang L, Jones K, Jablons D, Kim I. Abstract 108: Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas. Cancer Research 2016, 76: 108-108. DOI: 10.1158/1538-7445.am2016-108.
- Yang D, Woodard G, Zhou C, Wang X, Liu Z, Ye Z, Li K. Significance of different response evaluation criteria in predicting progression‐free survival of lung cancer with certain imaging characteristics. Thoracic Cancer 2016, 7: 535-542. PMID: 27766777, PMCID: PMC5130210, DOI: 10.1111/1759-7714.12363.
- Kang HC, Kim HK, Lee S, Mendez P, Kim JW, Woodard G, Yoon JH, Jen KY, Fang LT, Jones K, Jablons DM, Kim IJ. Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas. Oncotarget 2016, 7: 8321-8331. PMID: 26824986, PMCID: PMC4884995, DOI: 10.18632/oncotarget.7032.
- Yue D, Li H, Che J, Zhang Y, Tolani B, Mo M, Zhang H, Zheng Q, Yang Y, Cheng R, Jin JQ, Luh TW, Yang C, Tseng HH, Giroux-Leprieur E, Woodard GA, Hao X, Wang C, Jablons DM, He B. EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas. PLOS ONE 2015, 10: e0132134. PMID: 26132438, PMCID: PMC4488446, DOI: 10.1371/journal.pone.0132134.
- Woodard GA, Jablons DM. The Latest in Surgical Management of Stage IIIA Non-Small Cell Lung Cancer: Video-Assisted Thoracic Surgery and Tumor Molecular Profiling. American Society Of Clinical Oncology Educational Book 2015, e435-41. PMID: 25993207, DOI: 10.14694/edbook_am.2015.35.e435.
- Woodard G, Jablons D. Lung Cancer Stem Cells. 2015, 199-225. DOI: 10.1007/978-3-319-21030-8_8.
- Woodard GA, Gubens MA, Jahan TM, Jones KD, Kukreja J, Theodore PR, Cardozo S, Jew G, Clary-Macy C, Jablons DM, Mann MJ. Prognostic Molecular Assay Might Improve Identification of Patients At Risk for Recurrence in Early-Stage Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2014, 15: 426-432. PMID: 25258195, DOI: 10.1016/j.cllc.2014.07.004.
- Changchien EM, Woodard GA, Hernandez-Boussard T, Morton JM. Normal Alcohol Metabolism after Gastric Banding and Sleeve Gastrectomy: A Case-Cross-Over Trial. Journal Of The American College Of Surgeons 2012, 215: 475-479. PMID: 22770864, DOI: 10.1016/j.jamcollsurg.2012.06.008.
- Banka G, Woodard G, Hernandez-Boussard T, Morton JM. Laparoscopic vs Open Gastric Bypass Surgery: Differences in Patient Demographics, Safety, and Outcomes. JAMA Surgery 2012, 147: 550-556. PMID: 22786543, DOI: 10.1001/archsurg.2012.195.
- Woodard G, Ahmed S, Podelski V, Hernandez-Boussard T, Presti J, Morton J. Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigen. British Journal Of Surgery 2012, 99: 693-698. PMID: 22302466, DOI: 10.1002/bjs.8693.
- Woodard GA, Encarnacion B, Peraza J, Hernandez-Boussard T, Morton J. Halo Effect for Bariatric Surgery: Collateral Weight Loss in Patients' Family Members. JAMA Surgery 2011, 146: 1185-1190. PMID: 22006878, DOI: 10.1001/archsurg.2011.244.
- Woodard GA, Downey J, Hernandez-Boussard T, Morton JM. Impaired Alcohol Metabolism after Gastric Bypass Surgery: A Case-Crossover Trial. Journal Of The American College Of Surgeons 2010, 212: 209-214. PMID: 21183366, DOI: 10.1016/j.jamcollsurg.2010.09.020.
- Changchien E, Woodard G, Betti F, Hernandez-Boussard T, Morton J. P-125: Quality of life improves following gastric bypass, gastric banding and sleeve gastrectomy. Surgery For Obesity And Related Diseases 2010, 6: s68-s69. DOI: 10.1016/j.soard.2010.03.169.
- Changchien E, Woodard G, Hernandez-Boussard T, Morton J. P-121: Does gastric banding and sleeve gastrectomy alter alcohol metabolism? Surgery For Obesity And Related Diseases 2010, 6: s67. DOI: 10.1016/j.soard.2010.03.165.
- Woodard G, Brodsky JB, Morton JM. Cardiac Arrest During Laparoscopic Roux-en-Y Gastric Bypass in a Bariatric Patient with Drug-Associated Long QT Syndrome. Obesity Surgery 2010, 21: 134-137. PMID: 20383601, DOI: 10.1007/s11695-010-0137-8.
- Woodard G, Morton J. Bariatric outcomes. 2010 DOI: 10.1017/cbo9780511676307.024.
- Woodard GA, Peraza J, Bravo S, Toplosky L, Hernandez-Boussard T, Morton JM. One Year Improvements in Cardiovascular Risk Factors: a Comparative Trial of Laparoscopic Roux-en-Y Gastric Bypass vs. Adjustable Gastric Banding. Obesity Surgery 2010, 20: 578-582. PMID: 20186576, DOI: 10.1007/s11695-010-0088-0.
- Woodard G, Morton J. Chapter 7 Bariatric Surgery. 2010, 115-119.e2. DOI: 10.1016/b978-1-4160-6189-2.00007-x.
- Woodard G, Banka G, Morton J. Bariatric surgery improves male endocrine function. Journal Of The American College Of Surgeons 2009, 209: s21. DOI: 10.1016/j.jamcollsurg.2009.06.039.
- Woodard G, Hernandez-Boussard T, Morton J. M1588 Does Insurance Status Affect Gastric Bypass Surgery Outcomes? Gastroenterology 2009, 136: a-902. DOI: 10.1016/s0016-5085(09)64170-6.
- Bravo S, Woodard G, Hernandez-Boussard T, Morton J. M1590 Bariatric Surgery Improves Musculoskeletal Quality of Life Independent of Weight Loss and Procedure Type. Gastroenterology 2009, 136: a-903. DOI: 10.1016/s0016-5085(09)64172-x.
- Woodard GA, Encarnacion B, Downey JR, Peraza J, Chong K, Hernandez-Boussard T, Morton JM. Probiotics Improve Outcomes After Roux-en-Y Gastric Bypass Surgery: A Prospective Randomized Trial. Journal Of Gastrointestinal Surgery 2009, 13: 1198-1204. PMID: 19381735, DOI: 10.1007/s11605-009-0891-x.
- Woodard G, Downey J, Peraza J, Morton J. P70: Gastric bypass provides long-term improvement in cardiac risk factors. Surgery For Obesity And Related Diseases 2008, 4: 339. DOI: 10.1016/j.soard.2008.03.131.
- Noland S, Downey J, Brat G, Woodard G, Morton J. ST-04: Attitudes and outcomes for body contouring after gastric bypass surgery. Surgery For Obesity And Related Diseases 2008, 4: 369. DOI: 10.1016/j.soard.2008.03.033.
- Owens S, Downey J, Ramachandra T, Peraza J, Woodard G, Morton J. P71: Is there consensus for postoperative practice patterns? A survey of ASMBS surgeons. Surgery For Obesity And Related Diseases 2008, 4: 339-340. DOI: 10.1016/j.soard.2008.03.132.
- Hartley DM, Zhao C, Speier AC, Woodard GA, Li S, Li Z, Walz T. Transglutaminase Induces Protofibril-like Amyloid β-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation*. Journal Of Biological Chemistry 2008, 283: 16790-16800. PMID: 18397883, PMCID: PMC2423271, DOI: 10.1074/jbc.m802215200.
- Woodard G, Peraza J, Downey J, Encarnacion B, Morton J. 343 Probiotics Improve Weight Loss, GI-Related Quality of Life and H2 Breath Tests After Gastric Bypass Surgery: A Prospective Randomized Trial. Gastroenterology 2008, 134: a-846. DOI: 10.1016/s0016-5085(08)63955-4.
- Morton J, Woodard G, Hernandez-Boussard T. 779 Signal Detection: A New Statistical Method to Predict NASH in Gastric Bypass Patients. Gastroenterology 2008, 134: a-855. DOI: 10.1016/s0016-5085(08)64003-2.
- Woodard G, Morton J. Reporting of Bariatric Surgery Outcomes. 2008, 243-251. DOI: 10.1007/978-0-387-69171-8_30.
- Thoracic Oncology ProgramSmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 4thNew Haven, CT 06511
Biography
Gavitt Woodard, MD, is a thoracic surgeon who treats diseases that affect the chest. She specializes in the care of patients with lung cancer, and approaches each new patient as part of a multidisciplinary care team that also includes oncologists and radiation oncologists.
Patients are sometimes surprised to learn that lung cancer has undergone a “complete revolution” in the past decade, with screening CT scans, robotic surgery, genetic testing, targeted therapy, and immunotherapy, Dr. Woodard explains. “The vast majority of our early-stage lung cancer operations are done robotically with small incisions, less pain, and faster recovery times,” she says, adding that robotic technology is only going to improve with time.
Dr. Woodard says she always wanted to become a physician, but didn’t decide to become a surgeon until she was 16 years old and had surgery herself. “I love that surgery directly fixes a problem, the result is immediate, and it is so satisfying,” she says. “I considered many surgical specialties but was drawn to thoracic surgery because of the great lung anatomy, lung cancer biology, and the complexity of the operations.”
An assistant professor at Yale School of Medicine, Dr. Woodard performs research on biomarkers of early-stage lung cancer and on the tumor immune microenvironment in the laboratory of Lieping Chen, MD, PhD. Dr. Chen was the first to discover a protein called PD-L1, and he established the important role of this pathway in cancer immunotherapy.
Titles
- Assistant Professor of Surgery (Thoracic )
Education & Training
- Cardiothoracic Surgery FellowUniversity of California San Francisco (2020)
- General Surgery ResidentUniversity of California San Francisco (2018)
- MDStanford University (2011)
- BSHarvard University, Neurobiology (2006)
Additional Information
- SPORE in Lung Cancer Career Enhancement Program Grant: Yale (2022)
- Robotics Fellowship: American Association of Thoracic Surgeons (2019)
- Chief Resident Achievement Award: University of California San Francisco (2018)
- Resident Research Award, Best Presentation: University of California San Francisco (2016)
- Resident Research Award: American College of Surgeons (2015)
- Resident Research Award, Best Presentation: University of California San Francisco (2015)
- AB of Thoracic Surgery, Thoracic & Cardiac Surgery (2022)
- Zhan P, Boffa D, Woodard G. Further insights into MARS 2. The Lancet Respiratory Medicine 2024, 12: e52. PMID: 39214641, DOI: 10.1016/s2213-2600(24)00251-0.
- Woodard G, Jablons D. Shades of Gray: Do Never Smokers Benefit From Lung Cancer Screening Programs? Journal Of Thoracic Oncology 2024, 19: 1135-1137. PMID: 39111999, DOI: 10.1016/j.jtho.2024.06.007.
- Higaki A, Papageorge M, Waldron C, Huggins L, Brinker M, Erez E, Milewski R, Woodard G, Antonoff M, Lee M. Gender Representation Trends in Cardiothoracic Surgery Journal Editorial Boards. Journal Of Thoracic And Cardiovascular Surgery 2024 PMID: 38944272, DOI: 10.1016/j.jtcvs.2024.06.019.
- Detterbeck F, Woodard G, Bader A, Dacic S, Grant M, Park H, Tanoue L. The Proposed 9th Edition TNM Classification of Lung Cancer. CHEST Journal 2024 PMID: 38885896, DOI: 10.1016/j.chest.2024.05.026.
- Wang A, Rosenberg G, Woodard G, Dhanasopon A, Udelsman B. Image-guided and bronchoscopic localization techniques used to facilitate minimally invasive pulmonary metastasectomies. Video-Assisted Thoracic Surgery 2024, 0: 0-0. DOI: 10.21037/vats-23-80.
- Woodard G, Dacic S. Should the TNM Staging of NSCLC Evolve Beyond Anatomical Descriptors? Journal Of Thoracic Oncology 2024, 19: 663-665. PMID: 38719420, DOI: 10.1016/j.jtho.2024.01.004.
- Ely S, Van Udelsman B, Bader A, Woodard G. Chest Wall Anomaly Presenting as Pulmonary Nodule. Annals Of Thoracic Surgery Short Reports 2024, 2: 88-90. DOI: 10.1016/j.atssr.2023.11.021.
- Detterbeck F, Ely S, Udelsman B, Blasberg J, Boffa D, Dhanasopon A, Mase V, Woodard G. So Now We Know—Reflections on the Extent of Resection for Stage I Lung Cancer. Clinical Lung Cancer 2023, 25: e113-e123. PMID: 38310034, DOI: 10.1016/j.cllc.2023.12.007.
- Woodard G, Cho C, Chen L. Increased Lymphocyte Infiltration in NSCLC Neoadjuvant Chemo-Immunotherapy Non-responders: A Biomarker of T-Cell Dysfunction and Prognosis? Annals Of Surgical Oncology 2023, 31: 25-27. PMID: 37899411, DOI: 10.1245/s10434-023-14388-1.
- Udelsman B, Detterbeck F, Tanoue L, Mase V, Boffa D, Blasberg J, Dhanasopon A, Ely S, Mazzarelli L, Bader A, Woodard G. Impact of the COVID-19 Pandemic on Lung Cancer Screening Processes in a Northeast Tertiary Health Care Network. Journal Of Computer Assisted Tomography 2023, 48: 222-225. PMID: 37832536, DOI: 10.1097/rct.0000000000001549.
- Woodard G, Udelsman B, Prince S, Blasberg J, Dhanasopon A, Gange C, Traube L, Mase V, Boffa D, Detterbeck F, Bader A. Brief Report: Increasing Prevalence of Ground-Glass Nodules and Semisolid Lung Lesions on Outpatient Chest Computed Tomography Scans. JTO Clinical And Research Reports 2023, 4: 100583. PMID: 38074773, PMCID: PMC10709040, DOI: 10.1016/j.jtocrr.2023.100583.
- Woodard G, Ding V, Cho C, Brand N, Kratz J, Jones K, Jablons D. Comparative genomics between matched solid and lepidic portions of semi-solid lung adenocarcinomas. Lung Cancer 2023, 180: 107211. PMID: 37121213, PMCID: PMC10900430, DOI: 10.1016/j.lungcan.2023.107211.
- Grant M, Woodard G, Goldberg S. The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer. Hematology/Oncology Clinics Of North America 2023, 37: 513-531. PMID: 37024389, DOI: 10.1016/j.hoc.2023.02.003.
- Woodard G, Tanoue L, Detterbeck F, Boffa D, Mase V, Blasberg J, Dhanasopon A, Gosangi B, Traube L, Bader A. PP01.12 Increasing Diagnosis of Ground Glass Nodules and Semi-Solid Lung Lesions on Chest CT Scans over the Past Decade. Journal Of Thoracic Oncology 2023, 18: e15. DOI: 10.1016/j.jtho.2022.09.038.
- Woodard G, Boffa D, Blasberg J. Thoracic CT follow-up after non-small-cell lung cancer resection. The Lancet Oncology 2022, 23: e484. PMID: 36328013, DOI: 10.1016/s1470-2045(22)00618-0.
- Ely S, Udelsman B, Homer R, Dhanasopon A, Woodard G. EP14.05-021 Promising Long-Term Survival after Surgical Resection of Early Stage Small Cell Lung Cancer in a Modern Single-Center Cohort. Journal Of Thoracic Oncology 2022, 17: s552-s553. DOI: 10.1016/j.jtho.2022.07.996.
- Lee M, Woodard G, Assi R. Connection through cardiothoracic surgery subspecialty collaboration: Strategies for Early Faculty Peer Network Development. JTCVS Open 2022, 12: 329-334. PMID: 36590730, PMCID: PMC9801233, DOI: 10.1016/j.xjon.2022.07.008.
- Detterbeck FC, Mase VJ, Li AX, Kumbasar U, Bade BC, Park HS, Decker RH, Madoff DC, Woodard GA, Brandt WS, Blasberg JD. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 2: systematic review of evidence regarding resection extent in generally healthy patients. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813747, PMCID: PMC9264068, DOI: 10.21037/jtd-21-1824.
- Park HS, Detterbeck FC, Madoff DC, Bade BC, Kumbasar U, Mase VJ, Li AX, Blasberg JD, Woodard GA, Brandt WS, Decker RH. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of evidence involving SBRT and ablation. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813762, PMCID: PMC9264060, DOI: 10.21037/jtd-21-1826.
- Bade BC, Blasberg JD, Mase VJ, Kumbasar U, Li AX, Park HS, Decker RH, Madoff DC, Brandt WS, Woodard GA, Detterbeck FC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813753, PMCID: PMC9264070, DOI: 10.21037/jtd-21-1825.
- Detterbeck FC, Blasberg JD, Woodard GA, Decker RH, Kumbasar U, Park HS, Mase VJ, Bade BC, Li AX, Brandt WS, Madoff DC. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation— part 1: a guide to decision-making. Journal Of Thoracic Disease 2022, 0: 0-0. PMID: 35813719, PMCID: PMC9264102, DOI: 10.21037/jtd-21-1823.
- Woodard GA, Cho C, Chen L. Could Programmed Death-Ligand 1 Copy Number Alterations be a Predictive Biomarker for Immunotherapy Response? Journal Of Thoracic Oncology 2022, 17: 592-595. PMID: 35465963, DOI: 10.1016/j.jtho.2022.03.009.
- Combes A, Samad B, Tsui J, Chew N, Yan P, Reeder G, Kushnoor D, Shen A, Davidson B, Barczak A, Adkisson M, Edwards A, Naser M, Barry K, Courau T, Hammoudi T, Argüello R, Rao A, Olshen A, Consortium T, Spitzer M, Fong L, Nelson A, Kumar R, Lee J, Burra A, Hsu J, Hackett C, Tolentino K, Sjarif J, Johnson P, Shao E, Abrau D, Lupin L, Shaw C, Collins Z, Lea T, Corvera C, Nakakura E, Carnevale J, Alvarado M, Loo K, Chen L, Chow M, Grandis J, Ryan W, El-Sayed I, Jablons D, Woodard G, Meng M, Porten S, Okada H, Tempero M, Ko A, Kirkwood K, Vandenberg S, Guevarra D, Oropeza E, Cyr C, Glenn P, Bolen J, Morton A, Eckalbar W, Cai C, Zhan J, Davis K, Kelley R, Chapman J, Atreya C, Patel A, Daud A, Ha P, Diaz A, Kratz J, Collisson E, Fragiadakis G, Erle D, Boissonnas A, Asthana S, Chan V, Krummel M. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell 2021, 185: 184-203.e19. PMID: 34963056, PMCID: PMC8862608, DOI: 10.1016/j.cell.2021.12.004.
- Gupta AR, Woodard GA, Jablons DM, Mann MJ, Kratz JR. Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay. Future Oncology 2021, 17: 4785-4795. PMID: 34435876, PMCID: PMC9039775, DOI: 10.2217/fon-2021-0517.
- Woodard GA, Kratz JR, Haro G, Gubens MA, Blakely CM, Jones KD, Mann MJ, Jablons DM. Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non–Squamous Non–Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy. Clinical Lung Cancer 2021, 22: 587-595. PMID: 34544620, DOI: 10.1016/j.cllc.2021.08.008.
- Woodard GA, Li A, Boffa DJ. Role of adjuvant therapy in T1-2N0 resected non–small cell lung cancer. Journal Of Thoracic And Cardiovascular Surgery 2021, 163: 1685-1692. PMID: 34334172, DOI: 10.1016/j.jtcvs.2021.05.053.
- Woodard GA, Fels Elliott DR, Yap A, Haro GJ, Kratz JR, Mann MJ, Jones KD, Jablons DM. Resectability, Recurrence, and Risk Stratification of Giant Solitary Fibrous Tumors in the Thoracic Cavity. Annals Of Surgical Oncology 2021, 28: 4953-4959. PMID: 33728541, DOI: 10.1245/s10434-021-09757-7.
- Woodard G, Kratz J, Haro G, Gubens M, Blakely C, Jones K, Mann M, Jablons D. MO01.13 Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit from Adjuvant Chemotherapy. Journal Of Thoracic Oncology 2021, 16: s21. DOI: 10.1016/j.jtho.2020.10.061.
- Yang YW, Marrufo A, Chase J, Woodard GA, Jablons DM, Lemjabbar-Alaoui H. Ponatinib is a potential therapeutic approach for malignant pleural mesothelioma. Experimental Lung Research 2020, 47: 9-25. PMID: 33107354, DOI: 10.1080/01902148.2020.1836691.
- Hamilton B, Haro G, Woodard G, Sheu B, Kratz J, Mann M, Jablons D. Everybody Must Get Scanned? Molecular Risk Stratification May Limit the Need for CT Surveillance Following Surgical Resection of Early-Stage Non-Squamous, Non-Small Cell Lung Cancer. 2020, a7693-a7693. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7693.
- Woodard GA, Jablons DM. Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma. Translational Lung Cancer Research 2020, 9: s86-s91. PMID: 32206574, PMCID: PMC7082252, DOI: 10.21037/tlcr.2020.01.08.
- Haro GJ, Sheu B, Cook NR, Woodard GA, Mann MJ, Kratz JR. Comparison of Conventional TNM and Novel TNMB Staging Systems for Non–Small Cell Lung Cancer. JAMA Network Open 2019, 2: e1917062. PMID: 31808928, PMCID: PMC6902768, DOI: 10.1001/jamanetworkopen.2019.17062.
- Woodard G, Crockard J, Anand A, Ding V, Jones K, Gubens M, Blakely C, Jahan T, Jablons D. P2.06-09 Drop the Scalpel: Long-Term Survival in Mesothelioma Without Extrapleural Pneumonectomy or Pleurectomy Decortication. Journal Of Thoracic Oncology 2019, 14: s758-s759. DOI: 10.1016/j.jtho.2019.08.1627.
- Woodard G, Ding V, Kim I, Jones K, Chavez G, Haro G, Kratz J, Mann M, Rotow J, Blakely C, Jablons D. MA06.09 Timing of Driver Mutation Development and the Genetic Evolution of Semi-Solid Lung Nodules into Early NSCLC. Journal Of Thoracic Oncology 2019, 14: s271-s272. DOI: 10.1016/j.jtho.2019.08.544.
- Woodard GA, Lee H, Fels Elliott DR, Jones KD, Wong J, Jablons DM, Ihnken K. Case report: recurrent metastatic breast cancer in internal mammary dissection bed discovered at the time of coronary bypass. Journal Of Cardiothoracic Surgery 2019, 14: 158. PMID: 31488186, PMCID: PMC6728940, DOI: 10.1186/s13019-019-0980-1.
- Carbone M, Adusumilli PS, Alexander HR, Baas P, Bardelli F, Bononi A, Bueno R, Felley‐Bosco E, Galateau‐Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, Severson DT, Taioli E, Tsao A, Woodard G, Yang H, Zauderer MG, Pass HI. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA A Cancer Journal For Clinicians 2019, 69: 402-429. PMID: 31283845, PMCID: PMC8192079, DOI: 10.3322/caac.21572.
- Kratz JR, Haro GJ, Cook NR, He J, Van Den Eeden SK, Woodard GA, Gubens MA, Jahan TM, Jones KD, Kim IJ, He B, Jablons DM, Mann MJ. Incorporation of a Molecular Prognostic Classifier Improves Conventional Non–Small Cell Lung Cancer Staging. Journal Of Thoracic Oncology 2019, 14: 1223-1232. PMID: 30959120, DOI: 10.1016/j.jtho.2019.03.015.
- Woodard GA, Wieselthaler GM. Cast of the Right Bronchial Tree. New England Journal Of Medicine 2018, 379: 2151-2151. PMID: 30485771, DOI: 10.1056/nejmicm1806493.
- Rotow JK, Woodard GA, Urisman A, McCoach CE, Bivona TG, Elicker BM, Jablons DM, Blakely CM. Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation. Clinical Lung Cancer 2018, 20: e137-e141. PMID: 30553716, DOI: 10.1016/j.cllc.2018.11.003.
- Woodard G, Wang S, Kratz J, Haro G, Gubens M, Blakely C, Jahan T, Jones K, Mann M, Jablons D. P2.16-12 Expanded Data Confirm Molecular Testing Identifies Lung Adenocarcinoma Patients, Including Stage IA, Who Benefit from Adjuvant Chemotherapy. Journal Of Thoracic Oncology 2018, 13: s835. DOI: 10.1016/j.jtho.2018.08.1487.
- Haro G, Kratz J, Cook N, He J, Van Den Eeden S, Woodard G, Gubens M, Jahan T, Jones K, Kim I, He B, Jablons D, Mann M. P3.03-24 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging. Journal Of Thoracic Oncology 2018, 13: s919. DOI: 10.1016/j.jtho.2018.08.1701.
- Jablons D, Woodard G. MS31.03 Targeting the Hippo Pathway. Journal Of Thoracic Oncology 2018, 13: s306. DOI: 10.1016/j.jtho.2018.08.205.
- Mutti L, Peikert T, Robinson BWS, Scherpereel A, Tsao AS, de Perrot M, Woodard GA, Jablons DM, Wiens J, Hirsch FR, Yang H, Carbone M, Thomas A, Hassan R. Scientific Advances and New Frontiers in Mesothelioma Therapeutics. Journal Of Thoracic Oncology 2018, 13: 1269-1283. PMID: 29966799, PMCID: PMC6643278, DOI: 10.1016/j.jtho.2018.06.011.
- Wang S, Woodard G, Lucas C, Rogers S, Jablons D. 2460. Journal Of Clinical And Translational Science 2017, 1: 79-79. PMCID: PMC6799655, DOI: 10.1017/cts.2017.280.
- Woodard GA, Yang YL, You L, Jablons DM. Drug development against the hippo pathway in mesothelioma. Translational Lung Cancer Research 2017, 6: 335-342. PMID: 28713678, PMCID: PMC5504108, DOI: 10.21037/tlcr.2017.06.02.
- Woodard GA, Wang SX, Kratz JR, Zoon-Besselink CT, Chiang CY, Gubens MA, Jahan TM, Blakely CM, Jones KD, Mann MJ, Jablons DM. Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2017, 19: 58-64. PMID: 28645632, DOI: 10.1016/j.cllc.2017.05.015.
- Wang S, Woodard G, Umetsu S, Tsai K, Daud A, Jones K, Jablons D. Melanotic Schwannoma. AJSP Review And Reports 2017, 22: 161-163. DOI: 10.1097/pcr.0000000000000200.
- Kratz JR, Woodard G, Jablons DM. Management of Lung Cancer Invading the Superior Sulcus. Thoracic Surgery Clinics 2017, 27: 149-157. PMID: 28363369, DOI: 10.1016/j.thorsurg.2017.01.008.
- Woodard G, Zoon-Besselink C, Wang S, Jones K, Jablons D. P2.04-039 Long-Term Risk of Recurrence in Benign Pleural Solitary Fibrous Tumors: A Single Institution Review Topic: Esophageal Cancer and Other Malignancies. Journal Of Thoracic Oncology 2017, 12: s1020-s1021. DOI: 10.1016/j.jtho.2016.11.1419.
- Woodard G, Crockard J, Zoon-Besselink C, Kratz J, Gubens M, Jahan T, Blakely C, Jones K, Mann M, Jablons D. OA19.06 Adjuvant Chemotherapy Decisions Based on Molecular Risk Status Improves Outcomes in Early Stage, Non-Small Cell Lung Cancer. Journal Of Thoracic Oncology 2017, 12: s320. DOI: 10.1016/j.jtho.2016.11.341.
- Kratz J, Cook N, Woodard G, Jones K, Gubens M, Jahan T, Kim I, He B, Jablons D, Mann M. P1.03-066 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer TNM Staging Topic: Staging. Journal Of Thoracic Oncology 2017, 12: s584-s585. DOI: 10.1016/j.jtho.2016.11.738.
- Woodard G, Ding V, Rosenblum M, Leguay F, Zoon-Besselink C, Jones K, Lea T, Mcdermott M, Kim I, Jablons D. MA17.01 Microarray Identification of Genetic Drivers of Brain Metastasis in Lung Adenocarcinoma. Journal Of Thoracic Oncology 2017, 12: s441-s442. DOI: 10.1016/j.jtho.2016.11.515.
- Wang S, Woodard G, Rosenblum M, Zoon-Besselink C, Jones K, Jablons D. P3.01-013 Case Report of Melanotic Schwannoma: A Challenging Diagnosis Made Clear through Genetic Testing Topic: Morphology. Journal Of Thoracic Oncology 2017, 12: s1126. DOI: 10.1016/j.jtho.2016.11.1579.
- Kang HC, Kim JI, Chang HK, Woodard G, Choi YS, Ku JL, Jablons DM, Kim IJ. FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid. Scientific Reports 2016, 6: 34022. PMID: 27677402, PMCID: PMC5039724, DOI: 10.1038/srep34022.
- Woodard GA, Crockard JC, Clary‐Macy C, Zoon‐Besselink C, Jones K, Korn WM, Ko AH, Gottschalk AR, Rogers SJ, Jablons DM. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long‐term survival outcomes with minimal morbidity. Journal Of Surgical Oncology 2016, 114: 838-847. PMID: 27569043, DOI: 10.1002/jso.24409.
- Woodard GA, Jones KD, Jablons DM. Lung Cancer Staging and Prognosis. Cancer Treatment And Research 2016, 170: 47-75. PMID: 27535389, DOI: 10.1007/978-3-319-40389-2_3.
- Li H, Yue D, Jin JQ, Woodard GA, Tolani B, Luh TM, Giroux-Leprieur E, Mo M, Chen Z, Che J, Zhang Z, Zhou Y, Wang L, Hao X, Jablons D, Wang C, He B. Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas. Oncotarget 2016, 5: 80415-80425. PMID: 27533453, PMCID: PMC5348330, DOI: 10.18632/oncotarget.11246.
- Carbone M, Kanodia S, Chao A, Miller A, Wali A, Weissman D, Adjei A, Baumann F, Boffetta P, Buck B, de Perrot M, Dogan AU, Gavett S, Gualtieri A, Hassan R, Hesdorffer M, Hirsch FR, Larson D, Mao W, Masten S, Pass HI, Peto J, Pira E, Steele I, Tsao A, Woodard GA, Yang H, Malik S. Consensus Report of the 2015 Weinman International Conference on Mesothelioma. Journal Of Thoracic Oncology 2016, 11: 1246-1262. PMID: 27453164, PMCID: PMC5551435, DOI: 10.1016/j.jtho.2016.04.028.
- Kang H, Kim H, Lee S, Mendez P, Kim J, Woodard G, Jen K, Fang L, Jones K, Jablons D, Kim I. Abstract 108: Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas. Cancer Research 2016, 76: 108-108. DOI: 10.1158/1538-7445.am2016-108.
- Yang D, Woodard G, Zhou C, Wang X, Liu Z, Ye Z, Li K. Significance of different response evaluation criteria in predicting progression‐free survival of lung cancer with certain imaging characteristics. Thoracic Cancer 2016, 7: 535-542. PMID: 27766777, PMCID: PMC5130210, DOI: 10.1111/1759-7714.12363.
- Kang HC, Kim HK, Lee S, Mendez P, Kim JW, Woodard G, Yoon JH, Jen KY, Fang LT, Jones K, Jablons DM, Kim IJ. Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas. Oncotarget 2016, 7: 8321-8331. PMID: 26824986, PMCID: PMC4884995, DOI: 10.18632/oncotarget.7032.
- Yue D, Li H, Che J, Zhang Y, Tolani B, Mo M, Zhang H, Zheng Q, Yang Y, Cheng R, Jin JQ, Luh TW, Yang C, Tseng HH, Giroux-Leprieur E, Woodard GA, Hao X, Wang C, Jablons DM, He B. EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas. PLOS ONE 2015, 10: e0132134. PMID: 26132438, PMCID: PMC4488446, DOI: 10.1371/journal.pone.0132134.
- Woodard GA, Jablons DM. The Latest in Surgical Management of Stage IIIA Non-Small Cell Lung Cancer: Video-Assisted Thoracic Surgery and Tumor Molecular Profiling. American Society Of Clinical Oncology Educational Book 2015, e435-41. PMID: 25993207, DOI: 10.14694/edbook_am.2015.35.e435.
- Woodard G, Jablons D. Lung Cancer Stem Cells. 2015, 199-225. DOI: 10.1007/978-3-319-21030-8_8.
- Woodard GA, Gubens MA, Jahan TM, Jones KD, Kukreja J, Theodore PR, Cardozo S, Jew G, Clary-Macy C, Jablons DM, Mann MJ. Prognostic Molecular Assay Might Improve Identification of Patients At Risk for Recurrence in Early-Stage Non–Small-Cell Lung Cancer. Clinical Lung Cancer 2014, 15: 426-432. PMID: 25258195, DOI: 10.1016/j.cllc.2014.07.004.
- Changchien EM, Woodard GA, Hernandez-Boussard T, Morton JM. Normal Alcohol Metabolism after Gastric Banding and Sleeve Gastrectomy: A Case-Cross-Over Trial. Journal Of The American College Of Surgeons 2012, 215: 475-479. PMID: 22770864, DOI: 10.1016/j.jamcollsurg.2012.06.008.
- Banka G, Woodard G, Hernandez-Boussard T, Morton JM. Laparoscopic vs Open Gastric Bypass Surgery: Differences in Patient Demographics, Safety, and Outcomes. JAMA Surgery 2012, 147: 550-556. PMID: 22786543, DOI: 10.1001/archsurg.2012.195.
- Woodard G, Ahmed S, Podelski V, Hernandez-Boussard T, Presti J, Morton J. Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigen. British Journal Of Surgery 2012, 99: 693-698. PMID: 22302466, DOI: 10.1002/bjs.8693.
- Woodard GA, Encarnacion B, Peraza J, Hernandez-Boussard T, Morton J. Halo Effect for Bariatric Surgery: Collateral Weight Loss in Patients' Family Members. JAMA Surgery 2011, 146: 1185-1190. PMID: 22006878, DOI: 10.1001/archsurg.2011.244.
- Woodard GA, Downey J, Hernandez-Boussard T, Morton JM. Impaired Alcohol Metabolism after Gastric Bypass Surgery: A Case-Crossover Trial. Journal Of The American College Of Surgeons 2010, 212: 209-214. PMID: 21183366, DOI: 10.1016/j.jamcollsurg.2010.09.020.
- Changchien E, Woodard G, Betti F, Hernandez-Boussard T, Morton J. P-125: Quality of life improves following gastric bypass, gastric banding and sleeve gastrectomy. Surgery For Obesity And Related Diseases 2010, 6: s68-s69. DOI: 10.1016/j.soard.2010.03.169.
- Changchien E, Woodard G, Hernandez-Boussard T, Morton J. P-121: Does gastric banding and sleeve gastrectomy alter alcohol metabolism? Surgery For Obesity And Related Diseases 2010, 6: s67. DOI: 10.1016/j.soard.2010.03.165.
- Woodard G, Brodsky JB, Morton JM. Cardiac Arrest During Laparoscopic Roux-en-Y Gastric Bypass in a Bariatric Patient with Drug-Associated Long QT Syndrome. Obesity Surgery 2010, 21: 134-137. PMID: 20383601, DOI: 10.1007/s11695-010-0137-8.
- Woodard G, Morton J. Bariatric outcomes. 2010 DOI: 10.1017/cbo9780511676307.024.
- Woodard GA, Peraza J, Bravo S, Toplosky L, Hernandez-Boussard T, Morton JM. One Year Improvements in Cardiovascular Risk Factors: a Comparative Trial of Laparoscopic Roux-en-Y Gastric Bypass vs. Adjustable Gastric Banding. Obesity Surgery 2010, 20: 578-582. PMID: 20186576, DOI: 10.1007/s11695-010-0088-0.
- Woodard G, Morton J. Chapter 7 Bariatric Surgery. 2010, 115-119.e2. DOI: 10.1016/b978-1-4160-6189-2.00007-x.
- Woodard G, Banka G, Morton J. Bariatric surgery improves male endocrine function. Journal Of The American College Of Surgeons 2009, 209: s21. DOI: 10.1016/j.jamcollsurg.2009.06.039.
- Woodard G, Hernandez-Boussard T, Morton J. M1588 Does Insurance Status Affect Gastric Bypass Surgery Outcomes? Gastroenterology 2009, 136: a-902. DOI: 10.1016/s0016-5085(09)64170-6.
- Bravo S, Woodard G, Hernandez-Boussard T, Morton J. M1590 Bariatric Surgery Improves Musculoskeletal Quality of Life Independent of Weight Loss and Procedure Type. Gastroenterology 2009, 136: a-903. DOI: 10.1016/s0016-5085(09)64172-x.
- Woodard GA, Encarnacion B, Downey JR, Peraza J, Chong K, Hernandez-Boussard T, Morton JM. Probiotics Improve Outcomes After Roux-en-Y Gastric Bypass Surgery: A Prospective Randomized Trial. Journal Of Gastrointestinal Surgery 2009, 13: 1198-1204. PMID: 19381735, DOI: 10.1007/s11605-009-0891-x.
- Woodard G, Downey J, Peraza J, Morton J. P70: Gastric bypass provides long-term improvement in cardiac risk factors. Surgery For Obesity And Related Diseases 2008, 4: 339. DOI: 10.1016/j.soard.2008.03.131.
- Noland S, Downey J, Brat G, Woodard G, Morton J. ST-04: Attitudes and outcomes for body contouring after gastric bypass surgery. Surgery For Obesity And Related Diseases 2008, 4: 369. DOI: 10.1016/j.soard.2008.03.033.
- Owens S, Downey J, Ramachandra T, Peraza J, Woodard G, Morton J. P71: Is there consensus for postoperative practice patterns? A survey of ASMBS surgeons. Surgery For Obesity And Related Diseases 2008, 4: 339-340. DOI: 10.1016/j.soard.2008.03.132.
- Hartley DM, Zhao C, Speier AC, Woodard GA, Li S, Li Z, Walz T. Transglutaminase Induces Protofibril-like Amyloid β-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation*. Journal Of Biological Chemistry 2008, 283: 16790-16800. PMID: 18397883, PMCID: PMC2423271, DOI: 10.1074/jbc.m802215200.
- Woodard G, Peraza J, Downey J, Encarnacion B, Morton J. 343 Probiotics Improve Weight Loss, GI-Related Quality of Life and H2 Breath Tests After Gastric Bypass Surgery: A Prospective Randomized Trial. Gastroenterology 2008, 134: a-846. DOI: 10.1016/s0016-5085(08)63955-4.
- Morton J, Woodard G, Hernandez-Boussard T. 779 Signal Detection: A New Statistical Method to Predict NASH in Gastric Bypass Patients. Gastroenterology 2008, 134: a-855. DOI: 10.1016/s0016-5085(08)64003-2.
- Woodard G, Morton J. Reporting of Bariatric Surgery Outcomes. 2008, 243-251. DOI: 10.1007/978-0-387-69171-8_30.
- Thoracic Oncology ProgramSmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 4thNew Haven, CT 06511
- Thoracic Oncology ProgramSmilow Cancer Hospital at Yale New Haven35 Park Street, Fl 4thNew Haven, CT 06511